122 related articles for article (PubMed ID: 12623206)
1. Anti-parasitic activity of depudecin on Neospora caninum via the inhibition of histone deacetylase.
Kwon HJ; Kim JH; Kim M; Lee JK; Hwang WS; Kim DY
Vet Parasitol; 2003 Mar; 112(4):269-76. PubMed ID: 12623206
[TBL] [Abstract][Full Text] [Related]
2. Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase.
Kwon HJ; Owa T; Hassig CA; Shimada J; Schreiber SL
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3356-61. PubMed ID: 9520369
[TBL] [Abstract][Full Text] [Related]
3. Host cells participate in the in vitro effects of novel diamidine analogues against tachyzoites of the intracellular apicomplexan parasites Neospora caninum and Toxoplasma gondii.
Leepin A; Stüdli A; Brun R; Stephens CE; Boykin DW; Hemphill A
Antimicrob Agents Chemother; 2008 Jun; 52(6):1999-2008. PubMed ID: 18362190
[TBL] [Abstract][Full Text] [Related]
4. In vitro antiprotozoal effects of artemisinin on Neospora caninum.
Kim JT; Park JY; Seo HS; Oh HG; Noh JW; Kim JH; Kim DY; Youn HJ
Vet Parasitol; 2002 Jan; 103(1-2):53-63. PubMed ID: 11751000
[TBL] [Abstract][Full Text] [Related]
5. Induction of tachyzoite egress from cells infected with the protozoan Neospora caninum by nitro- and bromo-thiazolides, a class of broad-spectrum anti-parasitic drugs.
Esposito M; Moores S; Naguleswaran A; Müller J; Hemphill A
Int J Parasitol; 2007 Aug; 37(10):1143-52. PubMed ID: 17481636
[TBL] [Abstract][Full Text] [Related]
6. In vitro screening of the open source Pathogen Box identifies novel compounds with profound activities against Neospora caninum.
Müller J; Aguado A; Laleu B; Balmer V; Ritler D; Hemphill A
Int J Parasitol; 2017 Oct; 47(12):801-809. PubMed ID: 28751177
[TBL] [Abstract][Full Text] [Related]
7. The p38 MAPK inhibitor, SB203580, inhibits cell invasion by Neospora caninum.
Jin X; Gong P; Li G; Zhang X; Li J
Parasitol Res; 2017 Feb; 116(2):813-819. PubMed ID: 28039498
[TBL] [Abstract][Full Text] [Related]
8. Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase.
Darkin-Rattray SJ; Gurnett AM; Myers RW; Dulski PM; Crumley TM; Allocco JJ; Cannova C; Meinke PT; Colletti SL; Bednarek MA; Singh SB; Goetz MA; Dombrowski AW; Polishook JD; Schmatz DM
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13143-7. PubMed ID: 8917558
[TBL] [Abstract][Full Text] [Related]
9. Activities of 11-Azaartemisinin and N-Sulfonyl Derivatives against Neospora caninum and Comparative Cytotoxicities.
Harmse R; Wong HN; Smit FJ; Müller J; Hemphill A; N'Da DD; Haynes RK
ChemMedChem; 2017 Dec; 12(24):2094-2098. PubMed ID: 29210523
[TBL] [Abstract][Full Text] [Related]
10. Depudecin, a microbial metabolite containing two epoxide groups, exhibits anti-angiogenic activity in vivo.
Oikawa T; Onozawa C; Inose M; Sasaki M
Biol Pharm Bull; 1995 Sep; 18(9):1305-7. PubMed ID: 8845831
[TBL] [Abstract][Full Text] [Related]
11. Effects of miltefosine treatment in fibroblast cell cultures and in mice experimentally infected with Neospora caninum tachyzoites.
Debache K; Hemphill A
Parasitology; 2012 Jun; 139(7):934-44. PubMed ID: 22309643
[TBL] [Abstract][Full Text] [Related]
12. Neospora caninum and Toxoplasma gondii: a novel adhesion/invasion assay reveals distinct differences in tachyzoite-host cell interactions.
Naguleswaran A; Müller N; Hemphill A
Exp Parasitol; 2003; 104(3-4):149-58. PubMed ID: 14552862
[TBL] [Abstract][Full Text] [Related]
13. Tissue culture and explant approaches to studying and visualizing Neospora caninum and its interactions with the host cell.
Hemphill A; Vonlaufen N; Naguleswaran A; Keller N; Riesen M; Guetg N; Srinivasan S; Alaeddine F
Microsc Microanal; 2004 Oct; 10(5):602-20. PubMed ID: 15525434
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis and role in virulence of the histone deacetylase inhibitor depudecin from Alternaria brassicicola.
Wight WD; Kim KH; Lawrence CB; Walton JD
Mol Plant Microbe Interact; 2009 Oct; 22(10):1258-67. PubMed ID: 19737099
[TBL] [Abstract][Full Text] [Related]
15. Neospora caninum: functional inhibition of protein disulfide isomerase by the broad-spectrum anti-parasitic drug nitazoxanide and other thiazolides.
Müller J; Naguleswaran A; Müller N; Hemphill A
Exp Parasitol; 2008 Jan; 118(1):80-8. PubMed ID: 17720161
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cellular characterization of the detransformation agent, (-)-depudecin.
Shimada J; Kwon HJ; Sawamura M; Schreiber SL
Chem Biol; 1995 Aug; 2(8):517-25. PubMed ID: 9383455
[TBL] [Abstract][Full Text] [Related]
17. A novel compound, depudecin, induces production of transformation to the flat phenotype of NIH3T3 cells transformed by ras-oncogene.
Sugita K; Yoshida H; Matsumoto M; Matsutani S
Biochem Biophys Res Commun; 1992 Jan; 182(1):379-87. PubMed ID: 1731795
[TBL] [Abstract][Full Text] [Related]
18. Vero cell surface proteoglycan interaction with the microneme protein NcMIC(3) mediates adhesion of Neospora caninum tachyzoites to host cells unlike that in Toxoplasma gondii.
Naguleswaran A; Cannas A; Keller N; Vonlaufen N; Björkman C; Hemphill A
Int J Parasitol; 2002 Jun; 32(6):695-704. PubMed ID: 12062488
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships from in vitro efficacies of the thiazolide series against the intracellular apicomplexan protozoan Neospora caninum.
Esposito M; Müller N; Hemphill A
Int J Parasitol; 2007 Feb; 37(2):183-90. PubMed ID: 17141783
[TBL] [Abstract][Full Text] [Related]
20. In vitro effects of new artemisinin derivatives in Neospora caninum-infected human fibroblasts.
Müller J; Balmer V; Winzer P; Rahman M; Manser V; Haynes RK; Hemphill A
Int J Antimicrob Agents; 2015 Jul; 46(1):88-93. PubMed ID: 25934265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
